Similar Search Results

Pharmaceutical economics since the 1960s : plus ça change, plus c’est la même chose

Comanor, William S. - In: International journal of the economics of business 22 (2015) 2, pp. 169-171

Persistent link: https://www.econbiz.de/10011405917

[Rezension von: Pharmaceutical innovation: revolutionizing human health, ed. by Ralph Landau ...]

Comanor, William S. - In: Journal of economic literature 39 (2001) 3, pp. 944-945

Persistent link: https://www.econbiz.de/10001612430

Pharmaceutical markets in Japan and the United States

Comanor, William S. - In: International journal of economic policy studies 16 (2022) 2, pp. 355-370

Persistent link: https://www.econbiz.de/10013433326

Determinants of drug prices and expenditures

Comanor, William S.; Schweitzer, Stuart O. - In: Managerial and decision economics : MDE ; the … 28 (2007) 4/5, pp. 357-370

Persistent link: https://www.econbiz.de/10003543678

Mergers and innovation in the pharmaceutical market

Comanor, William S.; Scherer, Frederic M. - 2011

Persistent link: https://www.econbiz.de/10009487486

Pharmaceutical economics

Comanor, William S. (contributor); … - 2013

Persistent link: https://www.econbiz.de/10011498813

A special commemorative issue Honoring William S. Comanor and 50 years of pharmaceutical economics

Hay, Joel W. - In: International journal of the economics of business 22 (2015) 2, pp. 165-168

Persistent link: https://www.econbiz.de/10011405914

Strategic pricing of new pharmaceuticals

Lu, Z. John - In: The review of economics and statistics 80 (1998) 1, pp. 108-118

Persistent link: https://www.econbiz.de/10001235776

Value based pricing of pharmaceuticals in the US and UK : does centralized cost effectiveness analysis matter?

Comanor, William S.; Schweitzer, Stuart O.; Riddle, Jon M. - In: Review of industrial organization : RIO 52 (2018) 4, pp. 589-602

Persistent link: https://www.econbiz.de/10012008043

Pharmaceutical economics

Comanor, William S. - 2013

Pharmaceutical Economics begins with an investigation of the structure of the industry and its three main components: the research firms which produce innovative products; the generic drug industry and its expanding role; and the biotech industry, which is regarded as the future for...

Persistent link: https://www.econbiz.de/10011852149